Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026)
Camp4 Therapeutics (CAMP) posted Assets Average of $111.6 million for Q1 2026, up 9.33% sequentially from $102.1 million in Q4 2025, and up 58.25% YoY from $70.5 million in Q1 2025.
Analysis
Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Assets Average for 3 years, with the latest figure at $111.6 million in Q1 2026.
- Quarterly Assets Average rose 58.25% year-over-year to $111.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.6 million (up 58.25% YoY) and the FY2025 annual result came in at $98.1 million, up 47.17% from the prior year.
- Assets Average grew to $111.6 million in Q1 2026 per CAMP's latest filing, from $102.1 million in the prior quarter.
- Over five years, Assets Average peaked at $111.6 million in Q1 2026 and troughed at $49.8 million in Q4 2024.
- A 3-year average of $76.7 million and a median of $69.7 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average surged 104.88% in 2025, then jumped 58.25% in 2026.
- Over 3 years, Assets Average stood at $49.8 million in 2024, then jumped by 104.88% to $102.1 million in 2025, then gained by 9.33% to $111.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $111.6 million, $102.1 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.22 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 3.29 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.86 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - | 99.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.44 Mn |
| Mar 31, 2026 | 111.63 Mn |
| Dec 31, 2025 | 102.10 Mn |
| Sep 30, 2025 | 68.84 Mn |
| Jun 30, 2025 | 57.02 Mn |
| Mar 31, 2025 | 70.54 Mn |
| Dec 31, 2024 | 49.84 Mn |